Home » Stocks » TRXC

TransEnterix, Inc. (TRXC)

Stock Price: $4.54 USD 0.62 (15.82%)
Updated Mar 3, 2021 4:00 PM EST - Market closed
Market Cap 880.93M
Revenue (ttm) 2.76M
Net Income (ttm) -59.96M
Shares Out 97.54M
EPS (ttm) -1.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 3
Last Price $4.54
Previous Close $3.92
Change ($) 0.62
Change (%) 15.82%
Day's Open 4.93
Day's Range 4.39 - 5.30
Day's Volume 94,819,765
52-Week Range 0.28 - 6.95

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
InvestorPlace - 14 hours ago

Shares of TRXC stock are rising on Wednesday after the firm received general surgery clearance from the FDA for its Senhance Surgical System. The post TRXC Stock: Why Medical Device Play Asens...

Business Wire - 19 hours ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between th...

InvestorPlace - 1 day ago

TRXC stock is a better option than many “meme” stocks that retail investors have bid higher. It's a reminder that a little bit of homework can go a long way.

Zacks Investment Research - 2 days ago

TransEnterix (TRXC) closed at $3.72 in the latest trading session, marking no change from the prior day.

Business Wire - 2 days ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the...

The Motley Fool - 4 days ago

Shares of the robotic surgical-system manufacturer are soaring, but can this company become the next Intuitive Surgical?

InvestorPlace - 5 days ago

TRXC stock has pulled off a nice rally. But the company's systems could take some time to get traction.

InvestorPlace - 6 days ago

TRXC stock could become the next Intuitive Surgical. The company is funded, and has to simply develop its business now.

InvestorPlace - 1 week ago

TransEnterix announced a company renaming amid a broad selloff that had TRXC stock down more than 15% in trading today. The post TRXC Stock: What to Know as Red-Hot TransEnterix Falls 17% Toda...

Business Wire - 1 week ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve...

InvestorPlace - 1 week ago

TRXC stock has struggled badly since its 2014 IPO. A trader-driven rally is unlikely to change the concerning long-term trend.

InvestorPlace - 1 week ago

As TRXC stock takes a breather amid a sustained uptrend, investors should consider owning shares of this medical robotics innovator. The post Make a Surgical Strike With TransEnterix Stock app...

InvestorPlace - 1 week ago

With its ultra-low price point and the relevant business of minimally invasive surgeries, TRXC stock has garnered much attention. Still, prospective buyers should look at the broader context b...

Zacks Investment Research - 1 week ago

Is (TRXC) Outperforming Other Medical Stocks This Year?

InvestorPlace - 1 week ago

TRXC stock has potential to become the next Intuitive Surgical with its Senhance platform opening up a multi-billion dollar revenue stream The post TransEnterix Has A Compelling Case To Be The...

Other stocks mentioned: ISRG
Zacks Investment Research - 1 week ago

Does TransEnterix (TRXC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Business Wire - 1 week ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve...

InvestorPlace - 2 weeks ago

TransEnterix is facing competition from a number of much larger companies, while its revenue is quite low. Investors should take profits on TRXC stock.

InvestorPlace - 2 weeks ago

So, after contrasting the opportunities and risks with TRXC stock, what's the play? It may be interesting at lower prices.

InvestorPlace - 2 weeks ago

TransEnterix is currently trading above $5. But does TRXC stock have what it takes to be the next Intuitive Surgical?

InvestorPlace - 3 weeks ago

TransEnterix stock is up in trading today after a pair of big stock sales and ahead of its Feb. 23 Investor Day. The post TRXC Stock: Why TransEnterix Shares Are Soaring Today appeared first o...

InvestorPlace - 3 weeks ago

TRXC stock will do well over time, now that the company is well-capitalized. But does that mean it's a good time for new investors to hop on?

Business Wire - 3 weeks ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve...

The Motley Fool - 3 weeks ago

One robotic surgery company and one cybersecurity specialist are bound to impress in the long run.

Other stocks mentioned: CRWD
Zacks Investment Research - 1 month ago

Is (TRXC) Outperforming Other Medical Stocks This Year?

Business Wire - 1 month ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve...

InvestorPlace - 1 month ago

Surgical robotics is a fascinating market niche with huge potential, and you can capitalize on its expansion with a position in TRXC stock. The post Hold TransEnterix Stock as This Tiny Compan...

The Motley Fool - 1 month ago

Could there be more gains ahead for these recovering companies?

Other stocks mentioned: TELL, TLRY
Business Wire - 1 month ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the...

Business Wire - 1 month ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the...

Zacks Investment Research - 1 month ago

Does TransEnterix (TRXC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 1 month ago

TransEnterix (TRXC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

InvestorPlace - 1 month ago

Insider trading can give outside investors valuable clues and insights. This includes both insider buying and selling.

Other stocks mentioned: CAG, ESTE, GME, PRO, REVG, TPHS
The Motley Fool - 1 month ago

The robotic surgery specialist is helping to enhance the capabilities of surgeons, but its shares may have come too far, too fast.

InvestorPlace - 1 month ago

TransEnterix (TRXC) is seeing shares of TRXC stock soar higher on Tuesday following an update concerning its Intelligent Surgical Unit. The post TRXC Stock: 5 Things to Know About Surgical Rob...

Business Wire - 1 month ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve...

Seeking Alpha - 1 month ago

TransEnterix is developing a surgical robotic system to perform minimally invasive operations on the abdomen and pelvic region. The digital and AI-assisted system represents an alternative to ...

Business Wire - 1 month ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve...

Business Wire - 1 month ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve...

InvestorPlace - 1 month ago

Digital laparoscopy play TRXC stock is on the move Monday. Here's what you should know about the company TransEnterix right now.

Business Wire - 1 month ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve...

Zacks Investment Research - 1 month ago

As of late, it has definitely been a great time to be an investor in TransEnterix (TRXC).

Business Wire - 1 month ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Exe...

Zacks Investment Research - 2 months ago

TransEnterix (TRXC) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

GuruFocus - 2 months ago

Investors are probably going to do a double-take when they look at the five-year price chart for TransEnterix Inc. (TRXC). The North Carolina-based medical device company traded as high as $90...

Business Wire - 2 months ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve...

Business Wire - 2 months ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve...

Zacks Investment Research - 2 months ago

TransEnterix (TRXC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research - 2 months ago

Investors need to pay close attention to TransEnterix (TRXC) stock based on the movements in the options market lately.

Zacks Investment Research - 3 months ago

TransEnterix (TRXC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

About TRXC

Asensus Surgical engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. It digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through a new category of care called Digital Laparoscopy. The company's digital interface enables the use of capabilities, such as augmented intelligence, connectivity, and robotics in laparoscopy, as well as allows to address the current clinical, cognitive, and economic shortcomings in surgery. The company's produc... [Read more...]

Industry
Medical Devices
Founded
2006
CEO
Anthony Fernando
Employees
160
Stock Exchange
NYSEAMERICAN
Ticker Symbol
TRXC
Full Company Profile

Financial Performance

In 2019, TransEnterix's revenue was $8.53 million, a decrease of -64.60% compared to the previous year's $24.10 million. Losses were -$154.20 million, 149.6% more than in 2018.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for TransEnterix stock is "Buy." The 12-month stock price forecast is 1.45, which is a decrease of -68.06% from the latest price.

Price Target
$1.45
(-68.06% downside)
Analyst Consensus: Buy